Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Radcliffe Department of Medicine (RDM) group awarded £2.55 million for diabetes research.

Inside of a laboratory © Diabetes UK

Today the Type 1 Diabetes Grand Challenge, a ground-breaking partnership between the Steve Morgan Foundation, Diabetes UK and  Juvenile Diabetes Research Foundation (JDRF) UK, has announced funding of a research project led from the University, in a bid to find a cure for type 1 diabetes.

Professor David Hodson and his team will receive £2.55 million to explore how insulin-boosting molecules, which sit on the surface of beta cells, could be harnessed to create better performing lab-grown beta cells. They will also explore if the specialised molecules could help to protect transplanted beta cells from the immune system, or trigger new beta cells to grow inside the pancreas.

 

Read the full story on the Radcliffe Department of Medicine website.

Similar stories

New small molecule found to suppress the evolution of antibiotic resistance in bacteria

Researchers from the Ineos Oxford Institute for antimicrobial research (IOI) and the Department of Pharmacology at Oxford University, have developed a new small molecule that can suppress the evolution of antibiotic resistance in bacteria and make resistant bacteria more susceptible to antibiotics.